ANN ARBOR, Mich., Oct. 13, 2008 (GLOBE NEWSWIRE) -- Aastrom Biosciences (Nasdaq:ASTM) announces the following Webcast:

 What:     Aastrom Biosciences Fiscal Year 2008 Annual Meeting of
           Shareholders

 When:     Friday, October 17, 2008 @ 9:00 am (Eastern)

 Where:    http://www.investorcalendar.com/IC/CEPage.asp?ID=134463

 How:      For live Internet access, simply log on to the web at
           the link above.  Shareholders and other interested parties
           will be able to listen to the entire Annual Meeting of
           Shareholders.  After the business portion of the meeting,
           Aastrom will present a corporate slideshow update. Only
           shareholders in attendance at the meeting will be able to
           participate in the Question & Answer 
session.

If you are unable to listen to the live webcast, a replay of the meeting will be archived at http://www.investorcalendar.com/ until January 18, 2009.

About Aastrom Biosciences, Inc.

Aastrom is a leader in the development of autologous cell products for the repair or regeneration of human tissue. The Company's proprietary Tissue Repair Cell (TRC) technology involves the use of a patient's own cells to manufacture products to treat a range of chronic diseases and serious injuries. Aastrom's TRC-based products contain increased numbers of stem and early progenitor cells, produced from a small amount of bone marrow collected from the patient. The TRC technology platform has positioned Aastrom to advance multiple products into clinical development. Ongoing development activities are focused on applying TRC technology to cardiac and vascular tissue regeneration. The Company is currently focused on cardiovascular regeneration and is conducting a Phase II clinical trial with dilated cardiomyopathy (DCM) patients (the IMPACT-DCM trial) and a Phase IIb clinical trial with critical limb ischemia patients (the RESTORE-CLI trial).

The Aastrom Biosciences, Inc. logo is available at http://www.globenewswire.com/newsroom/prs/?pkgid=3663

CONTACT:  Aastrom Biosciences, Inc. 
          Investor Relations Department 
          Kris Maly 
          (734) 930-5777 
          mail@aastrom.com

(C) Copyright 2008 GlobeNewswire, Inc. All rights reserved.

News Provided by COMTEX